Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CXADR pseudogene 2 (CXADRP2) is a human genomic locus designated as a pseudogene by the HUGO Gene Nomenclature Committee (HGNC:33973). As a pseudogene, it is a non-functional DNA sequence similar to the functional "Coxsackie virus and adenovirus receptor" (CXADR) gene. Pseudogenes do not encode active proteins and typically lack the ability to serve as receptors, enzymes, or therapeutic targets. No direct biological, therapeutic, or disease-related functions have been attributed to CXADRP2, and there are no known drugs or biomarkers associated with this locus[5][3]. If you are interested in the active receptor, please refer to "Coxsackievirus and adenovirus receptor" (abbreviation: CAR, gene: CXADR), which is a well-characterized cell adhesion molecule and viral receptor with documented biological and clinical relevance[1][2][6][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on CXADR pseudogene 2 (CXADRP2).